Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T15:33:01.078Z Has data issue: false hasContentIssue false

Distribution of Central Line-Associated Bloodstream Infections Determined From Washington State’s Annual Reporting Validation Program, 2009–2013

Published online by Cambridge University Press:  28 December 2016

Jason M. Lempp*
Affiliation:
Division of Disease Control and Health Statistics, Washington State Department of Health, Olympia, Washington, United States
M. Jeanne Cummings
Affiliation:
Division of Disease Control and Health Statistics, Washington State Department of Health, Olympia, Washington, United States
David W. Birnbaum
Affiliation:
Applied Epidemiology, British Columbia, Canada.
*
Address correspondence to Jason M. Lempp, PO Box 33400, 10700 Meridian Ave N, Suite 100, Seattle, WA 98133 ([email protected]).

Abstract

Healthcare-associated infection reporting validation is essential because this information is increasingly used in public healthcare quality assurances and care reimbursement. Washington State’s validation of central line-associated bloodstream infection reporting applies credible quality sciences methods to ensure that hospital reporting accuracy is maintained. This paper details findings and costs from our experience.

Infect Control Hosp Epidemiol 2017;38:489–492

Type
Concise Communications
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATIONS: These findings were previously reported by J.M.L., M.J.C., and D.W.B. as a poster titled “Distribution of Central Line-Associated Bloodstream Infections Determined from Washington State’s Annual Reporting Validation Program, 2009–2013” at the Council of State and Territorial Epidemiologists (CSTE) Annual Conference in Nashville, Tennessee, on June 23, 2014, and by J.M.L., M.J.C., D.W.B., and P.G. Lovinger as a poster titled “Cost of a Sustainable Annual Validation Process to Ensure Credibility of State HAI Reporting” at the Council of State and Territorial Epidemiologists (CSTE) Annual Conference in Nashville, Tennessee, on June 23, 2014.

References

REFERENCES

1. Talbot, TR, Bratzler, DW, Carrico, RM, et al. Public reporting of health care-associated surveillance data: recommendations from the Healthcare Infection Control Practices Advisory Committee. Ann Intern Med 2013;159:631635.Google Scholar
2. Fortuna, JA, Brenneman, WA, Birnbaum, D, Brown, KL. The current state of validating the accuracy of clinical data reporting: lessons to be learned from quality and process improvement scientists. Infect Control Hosp Epidemiol 2013;34:611614.CrossRefGoogle ScholarPubMed
3. 2013 National and State Healthcare-Associated Infections Progress Report. Centers for Disease Control and Prevention website. www.cdc.gov/hai/progress-report/index.html. Published January 14, 2015. Accessed November 25, 2016.Google Scholar
4. Washington State Department of Health. Healthcare Associated Infection Program group Administrator Instructions for Validation of Surveillance Programs, version 1.0. Document DOH 200-001. Olympia, WA: Washington State Department of Health; September 2010.Google Scholar
5. Stephen, C. Capture-recapture methods in epidemiological studies. Infect Control Hosp Epidemiol 1996;17:262266.CrossRefGoogle ScholarPubMed
6. Washington State Office of Financial Management. General Service Salary Schedule for Represented Employees. Olympia, WA: Washington State Human Resources; 2014. Accessed December 7, 2016. Available at: http://dop.wa.gov/CompClass/JobClassesSalaries/Pages/ClassifiedJobListing.aspx Google Scholar
7. Zarate, R, Cummings, J, Birnbaum, D. A practical method to validate the accuracy of state-wide hospital infection surveillance. Abstract 842, Fifth Decennial International Conference on Healthcare-Associated Infections, Atlanta Georgia, March 2010.Google Scholar
8. Oh, JY, Cunningham, MC, Beldavs, ZG, et al. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009. Infect Control Hosp Epidemiol 2012;33:439445.CrossRefGoogle ScholarPubMed
9. Backman, LA, Melchreit, R, Rodriguez, R. Validation of the surveillance and reporting of central line-associated bloodstream infection data to a state health department. Am J Infect Control 2014;42:2833.CrossRefGoogle Scholar
10. Rich, KL, Reese, SM, Bol, KA, et al. Assessment of the quality of publicly reported central line-associated bloodstream infection data in Colorado, 2010. Am J Infect Control 2013;41:874879.CrossRefGoogle ScholarPubMed
11. 2012 National and State Healthcare-Associated Infections Standardized Infection Ratio Report. Centers for Disease Control and Prevention website. www.cdc.gov/hai/progress-report/index.html. Published March 29, 2012. Accessed November 25, 2016.Google Scholar
12. Kallen, AJ, Patel, PR, O’Grady, NP. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin Infect Dis 2010;51:335341.CrossRefGoogle ScholarPubMed
13. Climo, M, Diekema, D, Warren, DK, et al. Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 2003;24:942945.Google Scholar
14. Weber, DJ, Sickbert-Bennett, EE, Brown, V, Rutala, WA. Comparison of hospitalwide surveillance and targeted intensive care unit surveillance of healthcare-associated infections. Infect Control Hosp Epidemiol 2007;28:13611366.Google Scholar
15. Davis, J. Central-line-associated bloodstream infection: comprehensive, data-driven prevention. PA Patient Saf Advis 2011;8:100105.Google Scholar
Supplementary material: PDF

Lempp supplementary material

Lempp supplementary material 1

Download Lempp supplementary material(PDF)
PDF 466.4 KB